VestGen Advisors’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.72M Sell
25,916
-20,923
-45% -$5.79M 0.17% 129
2026
Q1
$13.4M Buy
46,839
+23,407
+100% +$6.95M 0.36% 56
2025
Q4
$6.4M Sell
23,432
-1,814
-7% -$493K 0.27% 88
2025
Q3
$6.82M Sell
25,246
-489
-2% -$133K 0.23% 101
2025
Q2
$7.09M Buy
25,735
+672
+3% +$183K 0.28% 83
2025
Q1
$6.65M Buy
+25,063
New +$6.18M 0.3% 76

Other funds holding CME

VestGen Advisors's CME Position: Q2 2026 in Review

VestGen Advisors reduced its CME Group (CME) stake by 45% in Q2 2026, selling an estimated $5.79M and leaving 25,916 shares worth $5.72M. The position accounts for 0.17% of the portfolio, ranked #129.

VestGen Advisors first reported a position in CME in Q1 2025 and has held it in 6 quarters since. The position peaked at $13.4M in Q1 2026. 1,694 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • VestGen Advisors held 25,916 shares of CME Group worth $5.72M as of Q2 2026.
  • VestGen Advisors sold 20,923 CME Group shares in Q2 2026, an estimated $5.79M.
  • CME Group made up 0.17% of VestGen Advisors's portfolio in Q2 2026, its #129 holding.
  • VestGen Advisors first reported a position in CME Group in Q1 2025 and has held it in 6 quarters since.
  • VestGen Advisors's CME Group position peaked at $13.4M in Q1 2026.
  • 1,694 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on VestGen Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.